Search
for
Sort by
Research 31–60 of 1000+
- DERMATOLOJİK ACİLLER
- Lichenoid red tatoo reaction and alopecia areata
- Treatment of Generalized Lichen Planus With Alefacept
- Alopecia areata during Interferon Alpha-2b/Ribavirin Therapy
- Cutaneous Manifestations in Thyroid Disorders
- Hair Loss in Autoimmune Cutaneous Bullous Disorders
- A STUDY OF MUCOCUTANEOUS MANIFESTATIONS IN AUTOIMMUNE CONNECTIVE TISSUE DISORDERS AT TERTIARY CARE CENTRE
- Hair Disorders in Autoimmune Diseases
- Skin Manifestations of Targeted Antineoplastic Therapy
- Topical use of systemic drugs in dermatology: A comprehensive review
- Cutaneous reactions to recombinant cytokine therapy
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- A Neglected case of Systemic lupus erythematosus presenting by Degos’ skin disease and diffuse non-scarring alopecia with dramatic response to treatment, clinically and dermoscopy.
- Diseases that Affect the Pinna
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- LUPUS PANNICULITIS AS AN INITIAL MANIFESTACION OF SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- Localized alopecic myxedema of the scalp
- Erosive pustular dermatosis of the scalp: challenges and solutions
- The influence of interferon on healthy and diseased skin
- Thyroid related skin manifestation and their association with autoimmune dermatology
- Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Vitamin D and Skin: An Review and Update
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Lichen planus – A refractory autoimmune disorder
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Lupus erythematosus: systemic and cutaneous manifestations
- Skin manifestations associated with systemic diseases – Part I
- Deucravacitinib in dermatology: current indication and existing off-label data
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy